These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2075460)

  • 41. Laboratory screening: a critique.
    Sackett DL
    Fed Proc; 1975 Nov; 34(12):2157-61. PubMed ID: 1102337
    [No Abstract]   [Full Text] [Related]  

  • 42. [Neonatal haemochromatosis: a new and promising horizon].
    Blasco Alonso J; González Gómez JM; Blasco Alonso M; Gil Gómez R; Navas López VM; Sierra Salinas C; González Escañuela E; Herrera Peral J
    An Pediatr (Barc); 2011 Feb; 74(2):139-40. PubMed ID: 21215717
    [No Abstract]   [Full Text] [Related]  

  • 43. HAEMOCHROMATOSIS.
    Lancet; 1952 Mar; 1(6709):650-1. PubMed ID: 14909511
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical chemistry and early diagnosis].
    Rommel K
    Med Welt; 1977 Jul; 28(29):1257-60. PubMed ID: 895467
    [No Abstract]   [Full Text] [Related]  

  • 45. Overlooked, tired and very angry.
    Stewart B
    Nurs Stand; 1996 Jan 17-23; 10(17):22-3. PubMed ID: 8602926
    [No Abstract]   [Full Text] [Related]  

  • 46. Primary and secondary haemochromatosis.
    Marx JJ
    Transfus Sci; 2000 Dec; 23(3):183-4. PubMed ID: 11099893
    [No Abstract]   [Full Text] [Related]  

  • 47. Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.
    Sundic T; Hervig T; Hannisdal S; Assmus J; Ulvik RJ; Olaussen RW; Berentsen S
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s84-9. PubMed ID: 24333062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening and early detection of hemochromatosis.
    McDonnell S; Grummer-Strawn L; Trowbridge F
    Am Fam Physician; 1997 Feb; 55(2):440-2. PubMed ID: 9054215
    [No Abstract]   [Full Text] [Related]  

  • 49. [Preclinical hereditary hemochromatosis--is there an indication for preventive screening?].
    Grønbaek KE; Milman N; Skødt V
    Ugeskr Laeger; 1995 Jul; 157(30):4249-50. PubMed ID: 7653009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory screening procedures and their clinical implications. Well-population screening.
    Whitby LG
    Proc R Soc Med; 1968 Aug; 61(8):763-6. PubMed ID: 5673396
    [No Abstract]   [Full Text] [Related]  

  • 51. Should asymptomatic haemochromatosis be treated? Consequences of screening must be made known.
    Nottingham J
    BMJ; 2000 Oct; 321(7266):956. PubMed ID: 11030698
    [No Abstract]   [Full Text] [Related]  

  • 52. Screening for haemochromatosis.
    Ulvik RJ
    Scand J Clin Lab Invest Suppl; 1990; 202():90-3. PubMed ID: 2075460
    [No Abstract]   [Full Text] [Related]  

  • 53. Haemochromatosis--a clinical update.
    Burt MJ; George DK; Powell LW
    Med J Aust; 1996 Mar; 164(6):348-51. PubMed ID: 8606660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.